NetMHCIIpan

NetMHCIIpan predicts peptide binding to Major Histocompatibility Complex class II (MHCII) molecules, which present peptides derived from endosomal proteins to T helper cells, to identify T cell epitopes for vaccine design and immunotherapy.

Key Features:

• Pan-specific prediction capability: Predicts peptide binding across HLA class II molecules with known protein sequences, including HLA-DR, HLA-DP, HLA-DQ, and mouse MHCII molecules.
• Pseudo-sequence representation: Defines the peptide-binding environment of MHCII molecules using a pseudo sequence approach applicable to HLA-DR, HLA-DP, and HLA-DQ.
• Comprehensive coverage (NetMHCIIpan-3.0): Implements a pan-specific predictor reported to cover all known sequences of HLA class II molecules.
• Benchmark performance: Has been evaluated in benchmarks showing improvements over molecule-specific prediction methods and the ability to predict binding for previously uncharacterized MHCII molecules.

Scientific Applications:

• Epitope discovery: Serves as a first-line computational approach to identify candidate CD4+ T cell epitopes from protein sequences.
• Immune response analysis: Aids in understanding antigen presentation by MHCII and T helper cell recognition of peptides derived from endosomal proteins.
• Vaccine and immunotherapy design: Supports selection of MHCII-restricted epitopes for vaccine candidates and immunotherapeutic strategies.
• Cross-species MHCII studies: Enables analysis of diverse MHC class II variants across species, facilitating inclusion of new MHC variants.

Methodology:

NetMHCIIpan uses a pseudo-sequence representation of MHCII peptide-binding environments for pan-specific binding prediction and has been evaluated by comparative benchmarks against molecule-specific predictors.